Infection Control Market to Reach Approximately USD 72 Billion by 2030, Driven by Advancements in Sterilization and Disinfection Technologies

Market Size

  • 2023 Market Value: USD 49.1 Billion
  • 2024 Estimate: USD 52.4 Billion
  • 2030 Forecast: USD 72.4 Billion
  • CAGR (2024–2030): ~6.1% (range 6.1%–6.7% across studies)

Overview

The Infection Control Market encompasses a broad array of products and services including sterilization equipment, disinfection agents and devices, personal protective equipment (PPE), endoscope reprocessing systems, antimicrobial surfaces, and contract-cleaning services. The market expansion is being propelled by rising healthcare-associated infection (HAI) concerns, increasing surgical volumes, and stringent regulatory requirements across healthcare, pharmaceutical, and long-term care industries.

To Know More About This Report Request A Free Sample Copy https://www.maximizemarketresearch.com/request-sample/1420/

Market Growth Drivers & Opportunities

Key Drivers

  • Surge in Surgical Procedures and hospitalization rates are driving demand for advanced sterilization and monitoring solutions.
  • Heightened Awareness of HAIs and related regulatory oversight is compelling healthcare facilities to invest in robust infection control infrastructures.
  • Technological Innovations, such as UV-C disinfection systems, automated sterilization robots, AI-based surveillance, and antimicrobial nanocoatings, are enhancing safety and efficiency.
  • Focus on Environmental & Sustainable Alternatives, including green disinfectants, reusable PPE, and no-touch automated systems.

Opportunities

  • Expansion into Non-Hospital Settings like outpatient clinics, dental practices, and home-care environments presents a growing market niche.
  • Outsourcing of Sterilization Services enables smaller healthcare facilities to tap specialist expertise and cost efficiencies.
  • Asia-Pacific Market Growth driven by rising healthcare infrastructure investments, rapid urbanization, and expanding access in emerging economies.

Segmentation Analysis

By Product Type

  • Sterilization Products & Services: Dominant segment (~42–47% share), driven by high demand in OR sterilization and endoscopy reprocessing.
  • Cleaning & Disinfection Products: Wipes, liquids, and disinfecting instruments maintain strong usage and recurring demand.
  • Personal Protective Barriers (PPE): Includes gowns, gloves, masks—significant, recurring components of disposables.
  • Endoscope Reprocessing Systems: Fastest-growing sub-segment due to procedural safety guidelines.
  • Antimicrobial Surface Coatings & Emerging Technologies: Gaining traction via infection prevention protocols.

By End User

  • Hospitals & Clinics: Largest consumer (>38% of global market); critical focus due to elevated HAI risks.
  • Ambulatory Surgical Centers and Outpatient Facilities: Fastest growing adoption due to procedural decentralization.
  • Pharmaceutical & Medical Device Manufacturers: High uptake driven by in-house sterilization needs.
  • Clinical Laboratories & Long-Term Care: Emerging demand for infection control services and equipment.

Major Manufacturers

Leading infection control companies driving innovation and market presence include:

  • 3M
  • STERIS
  • Getinge
  • Belimed
  • Ecolab
  • Cantel / Sotera
  • MMM Group
  • Matachana
  • Metrex Research
  • Cardinal Health
  • Steelco
  • Sterigenics (Sotera)
  • B. Braun
  • Olympus
  • Pal International
  • Clorox
  • SKYTRON

These organizations invest heavily in R&D, digital compliance systems, sterilization automation, and green disinfection products.

Get More Info: https://www.maximizemarketresearch.com/request-sample/1420/

Regional Analysis

  • North America: Holds the largest market share (~39–48%) due to strong regulatory enforcement, high HAI awareness, and infrastructure strength.
  • Asia-Pacific: Leading in growth rate (CAGR ~7–10%), driven by rapid urbanization, expanded healthcare access, and increasing hospital networks.
  • Europe: Robust market with strong public health initiatives, regulatory mandating, and healthcare facility standards.
  • Latin America, MEA: Gradually expanding as orthopedics and outpatient procedural growth intensify, overcoming budget and training limitations.

COVID‑19 Impact Analysis

The pandemic heightened hygiene awareness and accelerated adoption of infection control technologies. Investment surged in UV-C systems, automated sterilizers, disposable consumables, and remote monitoring platforms. Additionally, the strain on healthcare infrastructure triggered a pivot toward outsourced sterilization services to maintain compliance and capacity.

Commutator Analysis

Key components and technologies include:

  • Sterilizers: Steam, EtO, hydrogen peroxide vapor, E‑beam systems.
  • Automated Disinfection Robots: UV-C, no-touch systems for room decontamination.
  • Endoscope Reprocessors: Automated cleaning systems designed for endoscopic instruments.
  • Cleaning & Disinfectant Consumables: Wipes, liquids, sprays, surface agents.
  • PPE Solutions: Gloves, gowns, masks, face shields with antimicrobial properties.
  • Antimicrobial Surfaces: Nanocoatings, copper-infused surfaces to inhibit pathogen adhesion.
  • AI-Enabled Surveillance & Compliance Software: Monitor sterilization processes and ensure safety protocols.

Key Questions Answered

Question

Answer

What is the global market size today?

USD 49.1 Billion (2023), rising to USD 52.4 Billion (2024)

What is the projected value by 2030?

USD 72.4 Billion

What is the expected CAGR?

~6.1%–6.7% (2024–2030)

Which segment dominates by product?

Sterilization products & services (~45%)

Which sub-segment is growing fastest?

Endoscope reprocessing systems

Who are the major end users?

Hospitals and clinics

Which region leads market share today?

North America (~39–48%)

Which region is growing fastest?

Asia-Pacific (~7–10% CAGR)

 

Conclusion

The global infection control market is undergoing strong, sustained growth driven by the dual pressures of increasing procedural volumes and heightened awareness of HAIs. As the industry pivots toward sustainable, automated, and digitally integrated solutions, the investment emphasis on sterilization infrastructure and consumables continues to expand. Leading firms focusing on innovation, global access, and scalable partnerships across emerging markets are best positioned to shape the future of infection prevention and safety in healthcare.

About Maximize Market Research:
Maximize Market Research is a global market research and consulting company specializing in data-driven insights and strategic analysis. With a team of experienced analysts and industry experts, the company provides comprehensive reports across various sectors, aiding businesses in making informed decisions and achieving sustainable growth.

Contact Us
Maximize Market Research Pvt. Ltd.
2nd Floor, Navale IT Park, Phase 3
Pune-Bangalore Highway, Narhe
Pune, Maharashtra 411041, India
📞 +91 96073 65656
sales@maximizemarketresearch.com